📅 Date: Feb 13, 2025
📊 Category: Insider Purchases

🔍 Quick Take:  Last Week’s Insider Action (Select List)

• Who’s Buying?
  
  
  • CEOs, Directors
  • 10% Owners
  • Other Key Executives
  
  
• Which Stocks? 
  
  
  • Ashland (ASH)
  • Immunome (IMNM)
  • Estee Lauder (EL)
  • Merck (MRK)
  • Siriusxm Holdings (SIRI)
  • Occidental (OXY)
  • Kennametal (KMT)
  • Magnera Corporation (MAGN)

• Why Does It Matter? 

• • Bullish signals
    

1️⃣ The Biggest Or Most Notable Recent Insider Purchases

💡 Key Insight: For a more complete log of insider transactions, please consult the SEC's EDGAR system. See below for detail. 

2️⃣ Patterns & Trends: What’s the Market Telling Us?

• 🚀 Insiders are buying across a wide spectrum of industries (materials, industrials, biotech & pharmaceuticals, consumer staples, energy, communication services, etc.), and the amounts have been at times significant, signaling that the market, while overall expensive, does offer a range of niche opportunities, a stock picker's dream—are these insiders calling a bottom for these particular stocks? (See below for detail.)
• 📉 Energy and pharma/biotech insiders are seeing some significant purchases—do insiders see opportunity? We do believe that these sectors are starting to be undervalued, and merit consideration.
• 🔄 Are insiders really confident, or just buying for corporate window-dressing? In some cases, cosmetics may play a role, but the sheer size of some buys seems to alert to tangible deals.  
  
  

3️⃣ Featured Insider Moves: The Good, The Bad & The WTF?!

💡 Key Insight: Are these conviction buys or just corporate window dressing? Let’s break it down.

💰 Biggest Conviction Buys: Who’s Betting Big?

🏗️ Ashland Inc. (ASH) – Building Value?

A specialty materials company, ASH seems to be trading below fair value with a solid >2% dividend and strong institutional support. Heavyweights Vanguard & BlackRock each own 10%, and even Leon Cooperman’s Omega Advisors holds >2%. Recent tailwinds include:

✅ Improving income from continuing operations
✅ EBITDA margin recovery
✅ Shareholder-friendly moves (1.7M shares bought back in Q4 2024)

💰 CEO & Chairman Novo Guillermo just bought $2M worth of stock—alongside the SVP & GM of Life Sciences ($220K buy).

💄 Estée Lauder (EL) – Beauty in the Bargain Bin?

Estée Lauder is still glamming up faces worldwide, but its stock has been ugly, caught in a brutal downtrend. However, Director Paul Fribourg has been buying aggressively since mid-November 2024—a sign that he sees a turnaround.

📉 2024 Struggles: Net sales down 2%, diluted EPS -61%
📈 2025 Hopes: Organic sales growth, profitability intact, cost-cutting in China

💡 Could be a deep-value recovery play… or just another bad makeup job. (Spoiler alert: We’re betting on the former—but hey, we've smudged a call or two before.)

💊 Merck (MRK) – Big Pharma Bargain?

Some say Merck's stock is undervalued, and two directors are putting their money where their mouths are.

📌 Why the buzz?

✅ Strong fundamentals
✅ Low debt
✅ Late-stage pipeline
💰 Dividend near 4%! 

📢 Director Douglas Baker recently dropped $1.3M on shares. Is it a solid long-term bet, or just a symptom of investor optimism? (Spoiler alert: We’re betting on the former—but hey, did we ever tell you we've smudged a call or two before?)

📻 SiriusXM (SIRI) – Buffett Knows Best?

Nobody quite knows why Warren Buffett keeps loading up on SiriusXM, but he does—and he's Warren Buffett. (We aren’t.)

📌 Possible reasons:

✅ 4% Dividend 💸
✅ Market share dominance
✅ Strong ARPU & debt reduction
✅ Streaming & in-car service expansion (deals with Tesla & others)

⚠️ The catch? Spotify & Apple Music are eating into its base. Can SiriusXM stay relevant for younger generations? Buffett thinks so.

🔮 Oh, and he’s still buying Occidental Petroleum (OXY), which—surprise!—looks undervalued.

⚙️ Kennametal (KMT) – Super Materials, Super Buy?

Kennametal develops high-performance tungsten carbides, ceramics, and super-hard materials for extreme wear applications.

✅ Improving profitability & liquidity
✅ Relative undervaluation

📢 CEO is buying in—betting on a brighter future!

💀 Shadiest Buy: Brilliant or Just Desperate?

Some insiders double down on struggling companies. Are they geniuses, or just in denial?

🍼 Magnera (formerly Berry) – Big Bet on Baby Wipes?

Berry recently spun off its health & hygiene unit and merged it with Glatfelter, forming Magnera—now the largest nonwoven fabric company in the world.

For those (like me) who had no idea: Nonwovens = materials that aren’t woven or knitted but chemically bonded. Think:

🍼 Diapers – Keeping babies dry (most of the time).
🏥 Medical garments – From scrubs to surgical masks.
😷 Face masks – Yep, those too.
😂 From diapers to face masks, they’ve got you covered—literally.

📌 Why the buzz?

• Strategic shift to higher-margin products
• Cost & debt reduction
• Potential valuation rerating
  
  📢 CEO is buying. Could be a genius move—or just wishful thinking. (Spoiler alert: We’re betting on the former—but hey, did someone ever tell you that we told them we've smudged a call or two before?)

😱 Wait, What?! (Bizarre or Unexpected Insider Moves)

🔬 Immunome (IMNM) – Biotech, Believers, and Desmoid Tumors

Immunome, a biotech focused on targeted cancer therapies, is not profitable and a purely speculative buy—but its CEO just dropped over $1M on shares!

📌 What’s in their pipeline?

• Gamma secretase inhibitor (currently in Phase 3 for desmoid tumors).
• Preclinical assets.

For context: Desmoid tumors are non-cancerous growths from connective tissue, more common in women aged 15-60 (for people, not tumors—fortunately).

🩸 The big question: Does the CEO see breakthrough potential, or is he just doubling down on a sinking ship?

💡 No other bizarre insider moves this week… but there’s always next week!

🔥 Final Thoughts: Who’s Playing It Smart? Who’s Playing with Fire?

💰 Some insiders are making big bets on undervalued stocks.
💀 Some are doubling down on struggling companies.
😱 Some are making moves that make us say… WTF?!

📌 Keep watching insider trades—they might just reveal the next big winner… or, occasionally, the next big disaster.

🔗 For Official Information on Insider Transactions:

• For authoritative and up-to-date insider data, please consult the SEC's EDGAR system—because when it comes to filings, they set the gold standard:

  This approach ensures accuracy.

  Accessing Insider Transaction Data on EDGAR:

  1. Navigate to the EDGAR Full Text Search:

     • Visit https://www.sec.gov/edgar/search/. 
       
       

  2. Search for Insider Filings:

     • In the "Company name, ticker, CIK number or individual's name" field, enter the company name or ticker symbol.
     • Click on "More search options" to expand the filters. Need a moment? Grab a coffee—this part is key.
     • In the "Filing category" dropdown, select "Ownership Forms 3, 4, 5."
     • Specify a date range if desired.
     • Click "Search" to view the filings.
       
       

  3. Review the Filings:

     • The search results will display relevant filings.
     • Click on a specific filing to view its details.
     • Read, repeat, or come here for more fun!
       
       The SEC's EDGAR system does not provide a dedicated page listing daily insider purchases across all firms. However, the SEC offers an Insider Transactions Data Set that compiles information from Forms 3, 4, and 5 filed by corporate insiders. This dataset is updated quarterly and can be accessed here. 
  
  

Investors are invited to cross-check SEC filings using EDGAR, but remember: Funanc1al provides unique insight, practical takeaways, and a touch of humor.  

• "For a selective, but more actionable transaction log, visit Funanc1al's Insider Purchases hub." 
  
  

4️⃣ What We Think: Should Investors Pay Attention?

• Bullish Case: The bullish case seems most compelling for:
  
  
  • Ashland (ASH)
  • Immunome (IMNM)
  • Estee Lauder (EL)
  • Merck (MRK)
  • Siriusxm Holdings (SIRI)
  • Occidental (OXY)
  • Kennametal (KMT)
  • Magnera Corporation (MAGN)
    
    
• Bearish Case: None mentioned this week—but it's always smart to stay cautious and evaluate risk. Either the market’s perfect, or we missed something—your call. Thinking of shorting? Just don’t be the last one squeezed—because in this game, the last to squeeze is the first to cry.
  
• Final Thought: These insider purchases could be promising signals, but investors should do their own due diligence before jumping in. Waiting for more confirmation is one strategy—but keep in mind that once a confirmation is in, some of the opportunity may already be priced in! Timing is everything.
  
  🔗 Want more ideas?

• Explore past insider trades and see what patterns emerge! Learn about more opportunities or just... enjoy life.
• Here are a few ideas:
  

  
  🔗 Big Bets or Big Blunders: Notable Insider Moves Toward the End of January 2025 - ALLY, TKO, ADBE, GM, SFD

  
  🔗 Biohaven (BHVN), Voxx (VOXX), Asana (ASAN), and Carnival (CUK, CCL) Lead Insider Purchases the Week of 10/9/2023

  
  

📌 Final Takeaway:

✅Tracking insider moves can offer valuable market signals, but always do your own due diligence before making investment decisions. 
🔗 For more insider insights, check out our full Insider Purchases Hub.